Report : Asia Pacific Medical Robots Market Forecast to 2028 - COVID-19 Impact and Regional Analysis By Product (Surgical Robots, Hospital & Pharmacy Robots, Rehabilitation Robots, Non-Invasive Radiosurgery Robots, and Others), Application (Laparoscopy, Neurology, Orthopedics, Gynecology, Urology, Cardiology, and Others), and End User (Hospitals, Ambulatory Surgical Centers, and Others)

At 18.9% CAGR, the APAC Medical Robots Market is speculated to be worth US$ 5,351.40 million by 2028, says Business Market Insights       

According to Business Market Insights’ research, the APAC medical robots market was valued at US$ 1,893.25 million in 2022 and is expected to reach US$ 5,351.40 million by 2028, registering an annual growth rate of 18.9% from 2022 to 2028.  Evolution of nanorobots for cancer treatment and development of microswimmers are the critical factors attributed to the market expansion.                

Scientists are developing miniature robots, called microswimmers. The microswimmer can operate in different body parts, depending on its shape. The machines could swim through a person’s blood vessels to deliver medicine to a cancerous tumor. Moreover, the machine unclogs an artery to prevent a heart attack or even performs delicate vision-saving surgery from inside the eye. The robot could also make microscopic repairs in the blood vessels of the eye. These nanomachines could essentially patrol the circulatory system of the human body. They could be used to detect specific chemicals or toxins and give early warnings of organ failure or tissue rejection. Another potential function may include taking biometric measurements to monitor a person’s general health. A gel-like material is used to build a soft microrobot. By altering the gel’s temperature, robot can be made short and stumpy or long and needle-like. As continuously development in field of microswimmers support growth of the market in predicted period.  

On the contrary, high cost of surgical procedures and installation hurdles the growth of APAC medical robots market.  

Based on product, the APAC medical robots market is segmented into surgical robots, hospital & pharmacy robots, rehabilitation robots, non-invasive radiosurgery robots, and others. The surgical robots segment held 36.6% market share in 2022, amassing US$ 693.08 million. It is projected to garner US$ 1,915.46 million by 2028 to expand at 18.5% CAGR during 2022–2028.  

Based on application, the APAC medical robots market is segmented into laparoscopy, neurology, orthopedics, gynecology, urology, cardiology, and others. The laparoscopy segment held 36.0% market share in 2022, amassing US$ 682.42 million. It is projected to garner US$  1,946.51 million by 2028 to expand at 19.1% CAGR during 2022–2028.   

Based on end user, the APAC medical robots market is segmented into hospitals, ambulatory surgical centers and others.  The hospitals segment held 56.8% market share in 2022, amassing US$ 1,074.46 million. It is projected to garner US$ 3,081.80 million by 2028 to expand at 19.2% CAGR during 2022–2028.     

Based on country, the APAC medical robots market has been categorised into China, India, Japan, South Korea, Australia, and rest of APAC. Our regional analysis states that China captured 27.5% market share in 2022. It was assessed at US$ 521.09 million in 2022 and is likely to hit US$  1,515.31 million by 2028, exhibiting a CAGR of 19.5% during the forecast period.       

Key players dominating the APAC medical robots market are Accuray Incorporated, ARxIUM, Auris Medical, Ekso Bionics, Hocoma AG, Intuitive Surgicals, Kirby Lester, Medtronic, Omnicell Inc., and Stryker Corporation among others.     

  • In June 2022, Hocoma launched the ArmeoSenso, a sensor-based solution for patients with mild to moderate impairments of the upper extremity. The ArmeoSenso completes Hocoma’s modular Armeo Therapy Concept for all stages of arm and hand function recovery by allowing patients to extend their treatment beyond the clinic walls: Thanks to its easy-to-use interface and its lightweight and compact design, patients can continue to make progress in the comfort of their own home.
  • In May 2022, Medtronic and GE Healthcare announced a collaboration to meet growing need for outpatient care Providing excellent care inside and outside of the traditional hospital is the new normal for patients, clinicians, and payers seeking more choices without compromising excellent outcomes.

Contact Us
Contact Person: Sameer Joshi
Phone: +1- 646- 491- 9876
Email Id:

Download Free PDF Brochure